The Label · The Season, Not the Day
This name holds its markup label.
Oncotelic Therapeutics, Inc. holds its Markup at $0.03. The statistical read favours the buyers, held for 8 days.
As held on the ledger · 2026-09-07
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 8 days |
| Price at the screen | $0.03 |
| Valuation | 0.05 trailing · N/A forward price to earnings |
| Values screen | PASS |
| Beta | -0.24 |
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|
| Business activity |
Permissible |
Core business clean |
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. |
Pass |
| Debt load |
0.00% |
Below 33% |
Interest-bearing debt is just 0.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. |
Pass |
| Interest-bearing cash |
0.00% |
Below 33% |
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. |
Pass |
| Receivables |
0.00% |
Below 49% |
Money owed to the company is 0.0% of assets, under the 49% limit. |
Pass |
| Revenue purity |
0.00% |
Below 5% |
Only 0.0% of revenue comes from non-compliant sources, under the 5% line. |
Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Business, in Plain Words
The fundamentals · plain-English read
| Trailing P/E | 0.1xvery cheap relative to earnings |
| EPS, trailing | 0.59 |
| EPS, forward | 0.00 |
| Profit margin | 98,998.0%highly profitable on every dollar of sales |
| Return on equity | 182.6%an exceptional return on shareholder capital |
| FCF yield | -0.40% |
| Debt to equity | 0.05minimal debt: a conservative balance sheet |
| Current ratio | 0.08below 1: short-term bills exceed liquid assets |
| Beta | -0.24barely tracks the market's swings |
| Short interest, float | 0.03% |
| 52-week range | 0.02 - 0.11 |
| Market cap | $14M |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
OTLC trades on OQB. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.